Equities

Astena Holdings Co Ltd

8095:TYO

Astena Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)506.00
  • Today's Change1.00 / 0.20%
  • Shares traded215.50k
  • 1 Year change-1.75%
  • Beta0.5866
Data delayed at least 20 minutes, as of Nov 14 2024 05:21 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Nov 30 2023202320222021
ASSETS
Cash And Short Term Investments6,8816,92610,927
Total Receivables, Net19,55819,76817,370
Total Inventory10,7969,4899,338
Prepaid expenses------
Other current assets, total659567421
Total current assets37,89436,75038,057
Property, plant & equipment, net14,81213,12011,950
Goodwill, net4,0324,5124,395
Intangibles, net3,4273,7734,017
Long term investments4,8423,8143,613
Note receivable - long term------
Other long term assets325357530
Total assets67,25563,55263,554
LIABILITIES
Accounts payable12,09012,14512,141
Accrued expenses3,3843,1263,857
Notes payable/short-term debt11,0699,0008,000
Current portion long-term debt/capital leases1,2831,1371,162
Other current liabilities, total2,1562,3841,479
Total current liabilities29,98227,79226,639
Total long term debt4,6404,9145,999
Total debt16,99215,05115,161
Deferred income tax966729937
Minority interest181826.59
Other liabilities, total3,0663,0482,972
Total liabilities38,83436,56536,554
SHAREHOLDERS EQUITY
Common stock4,5814,5574,528
Additional paid-in capital6,5746,5396,517
Retained earnings (accumulated deficit)15,46215,03215,027
Treasury stock - common(526)(532)(254)
Unrealized gain (loss)1,7031,007986
Other equity, total625383196
Total equity28,42026,98727,000
Total liabilities & shareholders' equity67,25563,55263,554
Total common shares outstanding393940
Treasury shares - common primary issue1.391.390.75
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.